bioAffinity Technologies (BIAF) Cash & Current Investments (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Cash & Current Investments of $3.1 million for Q1 2026, up 674.59% year-over-year from $400000.0 in Q1 2025, and down 51.96% quarter-over-quarter from $6.4 million in Q4 2025.
bioAffinity Technologies (BIAF) Cash & Current Investments (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Cash & Current Investments for 6 consecutive years, with $3.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments rose 674.59% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (up 674.59% YoY), while the FY2025 annual figure was $6.4 million, up 483.54% from the prior year.
- Cash & Current Investments eased to $3.1 million in Q1 2026 per BIAF's latest filing, from $6.4 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $13.5 million in Q3 2022 and bottomed at $400000.0 in Q1 2025.
- Historically, Cash & Current Investments has averaged $4.9 million across 5 years, with a median of $3.1 million in 2026.
- Annual changes were most pronounced in 2024 — Cash & Current Investments plunged 90.36% — and 2025, when it surged 913.67%.
- bioAffinity Technologies' Cash & Current Investments stood at $11.4 million in 2022, then sank by 75.28% to $2.8 million in 2023, then sank by 60.83% to $1.1 million in 2024, then soared by 483.54% to $6.4 million in 2025, then sank by 51.96% to $3.1 million in 2026.
- Business Quant data shows BIAF's Cash & Current Investments at $3.1 million in Q1 2026, $6.4 million in Q4 2025, and $7.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 4.06 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 4.35 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 1.10 Bn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 1.81 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 2.08 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 196.93 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 1.17 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 51.40 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 141.80 Mn |
| 10 | bioAffinity Technologies | 1.78 Mn | -649,139.45 | - | 2.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.43 Mn |
| Mar 31, 2026 | 3.10 Mn |
| Dec 31, 2025 | 6.45 Mn |
| Sep 30, 2025 | 7.70 Mn |
| Jun 30, 2025 | 802,835.00 |
| Mar 31, 2025 | 444,706.00 |
| Dec 31, 2024 | 1.11 Mn |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 801,311.00 |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 2.82 Mn |
| Sep 30, 2023 | 4.51 Mn |
| Jun 30, 2023 | 8.30 Mn |
| Mar 31, 2023 | 9.80 Mn |
| Dec 31, 2022 | 11.41 Mn |
| Sep 30, 2022 | 13.50 Mn |
| Dec 31, 2021 | 1.36 Mn |